US Stock MarketDetailed Quotes
NRSNW NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM)
- 0.1200
- 0.00000.00%
Close Oct 3 15:58 ET
0.0000High0.0000Low
0.0000High0.0000Low0Volume0.0000Open0.1200Pre Close0.00Turnover0.00%Turnover Ratio--P/E (Static)0Shares0.650052wk High--P/B0Float Cap0.073052wk Low--Dividend TTM0Shs Float1.9500Historical High--Div YieldTTM0.00%Amplitude0.0730Historical Low--Avg Price1Lot Size
About NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) Company
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company. The firm is focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. It is involved in the 2b/3 clinical trial using its product candidate, PrimeC in patients with ALS and also commencing research into other possible indications for the drug, including Alzheimer’s and Parkinson’s diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.
Company Profile
SymbolNRSNW
Company NameNEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM)
Listing DateDec 9, 2021
Founded2017
CEOMr. Alon Ben-Noon
MarketNASDAQ
Employees16
Fiscal Year Ends12-31
Address11 HaMenofim Street,Building B
CityHerzliya
ProvinceTel Aviv
CountryIsrael
Zip Code46725
Phone972-9-799-6183
Websitehttp://www.neurosense-tx.com
Company Executives
- Name
- Position
- Salary
- Alon Ben-Noon
- Chief Executive Officer and Director
- 1.01M
- Dr. Ferenc Tracik
- Chief Medical Officer
- 918.00K
- Or Eisenberg
- Chief Financial Officer and Principal Accounting Officer
- 1.02M
- Dr. Niva Russek-Blum
- Chief Technology Officer
- 245.00K
- Hagit Binder
- Chief Operating Officer
- 219.00K
- Mark W. Leuchtenberger
- Chairman of the Board
- 1.48M
- Dr. Revital Mandil-Levin
- Director
- --
- Caren Deardorf
- Independent Director
- 91.00K
- Christine A. Pellizzari
- Independent Director
- 104.00K
- Cary J Claiborne
- Independent Director
- 104.00K